The "Insulin for All Act of 2023" aims to address the rising costs of insulin by making it more affordable and accessible. The main provisions include capping the out-of-pocket cost of insulin at $35 per month for individuals with health insurance, expanding access to lower-cost generic insulin, and increasing transparency in pricing. This bill seeks to alleviate financial burdens on individuals with diabetes and ensure they can afford this life-saving medication. If passed, it could significantly reduce healthcare costs for many Americans who rely on insulin to manage their condition.
2023-03-09: Introduced in House
2023-03-09: Referred to the House Committee on Energy and Commerce.
Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.
No Reviews found ..